title: Lamotrigine in the treatment of SUNCT syndrome.
abstract: Short-lasting, unilateral, neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) is considered an intractable condition. The authors treated five patients with lamotrigine (125 to 200 mg daily), obtaining a complete remission in three patients and a substantial reduction (about 80%) of attack frequency in the other two. No adverse effects were noted.
authors.affiliation: Headache and Comorbidity Center, Pathology Unit, Este-Monselice Hospital, Este, Italy.
authors.forename: G
authors.initials: G
authors.lastname: D'Andrea
authors.forename: F
authors.initials: F
authors.lastname: Granella
authors.forename: N
authors.initials: N
authors.lastname: Ghiotto
authors.forename: G
authors.initials: G
authors.lastname: Nappi
mesh_terms: D000328:Adult; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D005260:Female; D020773:Headache Disorders / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D000077213:Lamotrigine; D008297:Male; D008875:Middle Aged; D014227:Triazines / Q000627:therapeutic use*
chemical_list: D000700:Analgesics; D014227:Triazines; D000077213:Lamotrigine